Q&A with Dr. Mélanie Uguen: Exploring a Promising Drug Target for Cancer

Abnormal gene expression is linked with disease development, especially cancer. Melanie Uguen, PhD, of the University of North Carolina at Chapel Hill received a 2023 PhRMA Foundation Postdoctoral Fellowship in Drug Discovery for her work to exploring multiple strategies to develop a drug targeting SETDB1, a protein involved in the gene expression process. Watch this video to learn about Uguen and her research.